Both in Biotechnology
Iovance Biotherapeutics vs CG Oncology
Over the past year IOVA returned +548.0% and CGON returned +80.5%; their daily moves had a correlation of 0.21.
IOVA +548.0% CGON +80.5%Growth of $1, one year, split-adjusted
| Metric | IOVA | CGON |
|---|---|---|
| Price | $14.45 | $70.52 |
| Market cap | $6.55B | $6.25B |
| Today | +31.48% | +1.31% |
| 1 month | +80.4% | −5.1% |
| 6 months | +335.2% | +10.3% |
| Year to date | +429.3% | +69.8% |
| 1 year | +584.8% | +87.9% |
| Revenue growth (YoY) | +65.7% | — |
| Gross margin | 56.1% | −239.2% |
| Net margin | −47.6% | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | 20.1× | 1,003.7× |
| Net cash | $297.7M | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 119.4% | 46.5% |
| Short % of float | 22.4% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).